Literature DB >> 11525806

Allelic expression and interleukin-2 polymorphisms in multiple sclerosis.

F Matesanz1, M Fedetz, M Collado-Romero, O Fernández, M Guerrero, C Delgado, A Alcina.   

Abstract

We have investigated the association of two single nucleotide polymorphisms (SNPs) at positions -384 and 114 in the human interleukin-2 (hIL-2) with multiple sclerosis (MS). For two of the -384 genotypes (G/T, T/T), we observed an association with the susceptibility to secondary progressive (SP) course of MS (P=0.005 and P=0.013, respectively). Expression level differences of the IL-2 alleles (between one- and three-fold) were not attributable to the -384 promoter polymorphism. These data indicate for the first time the relevance of the il-2 gene locus in human MS and its possible involvement in other autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11525806     DOI: 10.1016/s0165-5728(01)00354-x

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  24 in total

1.  Polymorphisms in the IL2, IL2RA and IL2RB genes in multiple sclerosis risk.

Authors:  María L Cavanillas; Antonio Alcina; Concepción Núñez; Virginia de las Heras; Miguel Fernández-Arquero; Manuel Bartolomé; Emilio G de la Concha; Oscar Fernández; Rafael Arroyo; Fuencisla Matesanz; Elena Urcelay
Journal:  Eur J Hum Genet       Date:  2010-02-24       Impact factor: 4.246

2.  IL-2 gene C/T polymorphism is associated with prostate cancer.

Authors:  Hsi-Chin Wu; Chao-Hsiang Chang; Lei Wan; Chao-I Wu; Fuu-Jen Tsai; Wen-Chi Chen
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

3.  Interleukin 2 gene polymorphisms are associated with non-Hodgkin lymphoma.

Authors:  Haihan Song; Lei Chen; Zhanshan Cha; Jianwen Bai
Journal:  DNA Cell Biol       Date:  2012-04-03       Impact factor: 3.311

Review 4.  T-cell tolerance and the multi-functional role of IL-2R signaling in T-regulatory cells.

Authors:  Guoyan Cheng; Aixin Yu; Thomas R Malek
Journal:  Immunol Rev       Date:  2011-05       Impact factor: 12.988

5.  Use of duplex PCR-CTPP methods for CYP2E1RsaI/IL-2 T-330G and IL-1B C-31T/TNF-A T-1031C polymorphisms.

Authors:  Yoshiko Atsuta; Haruya Kawase; Nobuyuki Hamajima; Kazuko Nishio; Yoshimitsu Niwa; Daisuke Tanaka; Kazuhito Yamamoto; Akiko Tamakoshi
Journal:  Mol Diagn       Date:  2005

6.  Genetics of experimental allergic encephalomyelitis supports the role of T helper cells in multiple sclerosis pathogenesis.

Authors:  Elizabeth P Blankenhorn; Russell Butterfield; Laure K Case; Emma H Wall; Roxana del Rio; Sean A Diehl; Dimitry N Krementsov; Naresha Saligrama; Cory Teuscher
Journal:  Ann Neurol       Date:  2011-12       Impact factor: 10.422

Review 7.  Beyond regulatory T cells: the potential role for IL-2 to deplete T-follicular helper cells and treat autoimmune diseases.

Authors:  André Ballesteros-Tato
Journal:  Immunotherapy       Date:  2014       Impact factor: 4.196

8.  A 33D1+ Dendritic Cell/Autoreactive CD4+ T Cell Circuit Maintains IL-2-Dependent Regulatory T Cells in the Spleen.

Authors:  J Michael Stolley; Daniel J Campbell
Journal:  J Immunol       Date:  2016-08-26       Impact factor: 5.422

Review 9.  Dysregulation of T Follicular Helper Cells in Lupus.

Authors:  John D Mountz; Hui-Chen Hsu; Andre Ballesteros-Tato
Journal:  J Immunol       Date:  2019-03-15       Impact factor: 5.422

10.  Population pharmacokinetics of daclizumab high-yield process in healthy volunteers: integrated analysis of intravenous and subcutaneous, single- and multiple-dose administration.

Authors:  Ahmed A Othman; Jonathan Q Tran; Meina T Tang; Sandeep Dutta
Journal:  Clin Pharmacokinet       Date:  2014-10       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.